Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon DeMorrow

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
American Journal of Physiology. Cell Physiology|July 20, 2007
The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated ratsHeather Francis, Gene LeSage, Sharon DeMorrow, et al.
Scientific Reports|January 21, 2017
Hepatic alterations are accompanied by changes to bile acid transporter-expressing neurons in the hypothalamus after traumatic brain injuryDamir Nizamutdinov, Sharon DeMorrow, Matthew McMillin, et al.
International Journal of Cancer|April 10, 2009
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosisPaolo Onori, Sharon DeMorrow, Eugenio Gaudio, et al.
The American Journal of Pathology|January 19, 2020
Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout MiceAnca D Petrescu, Stephanie Grant, Elaina Williams, et al.
American Journal of Physiology. Cell Physiology|December 29, 2006
Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2+)-dependent downregulation of SRC/ERK1/2Giammarco Fava, Yoshiyuki Ueno, Shannon Glaser, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 6, 2017
The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammalsNan Wu, Quy Nguyen, Ying Wan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 6, 2011
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptorLi Huang, Jonathan C Ramirez, Gabriel A Frampton, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2007
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathwayHeather Francis, Antonio Franchitto, Yoshiyuki Ueno, et al.
Gut|August 30, 2011
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaHeather Francis, Sharon DeMorrow, Julie Venter, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regenerationFanyin Meng, Heather Francis, Shannon Glaser, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
American Journal of Physiology. Cell Physiology|July 20, 2007
The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated ratsHeather Francis, Gene LeSage, Sharon DeMorrow, et al.
Scientific Reports|January 21, 2017
Hepatic alterations are accompanied by changes to bile acid transporter-expressing neurons in the hypothalamus after traumatic brain injuryDamir Nizamutdinov, Sharon DeMorrow, Matthew McMillin, et al.
International Journal of Cancer|April 10, 2009
Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosisPaolo Onori, Sharon DeMorrow, Eugenio Gaudio, et al.
The American Journal of Pathology|January 19, 2020
Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout MiceAnca D Petrescu, Stephanie Grant, Elaina Williams, et al.
American Journal of Physiology. Cell Physiology|December 29, 2006
Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP(3)/Ca(2+)-dependent downregulation of SRC/ERK1/2Giammarco Fava, Yoshiyuki Ueno, Shannon Glaser, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 6, 2017
The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammalsNan Wu, Quy Nguyen, Ying Wan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 6, 2011
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptorLi Huang, Jonathan C Ramirez, Gabriel A Frampton, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2007
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathwayHeather Francis, Antonio Franchitto, Yoshiyuki Ueno, et al.
Gut|August 30, 2011
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaHeather Francis, Sharon DeMorrow, Julie Venter, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regenerationFanyin Meng, Heather Francis, Shannon Glaser, et al.
Pageof 13